Ausgabe 6/2018
Inhalt (12 Artikel)
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
Michael Rückert, Lisa Deloch, Rainer Fietkau, Benjamin Frey, Markus Hecht, Udo S. Gaipl
Occurrence of pneumonitis following radiotherapy of breast cancer – A prospective study
Danijela Vasiljevic, Christoph Arnold, David Neuman, Katharina Fink, Marina Popovscaia, Irma Kvitsaridze, Meinhard Nevinny-Stickel, Markus Glatzer, Peter Lukas, Thomas Seppi
Patient-reported symptoms before palliative radiotherapy predict survival differences
Carsten Nieder, Thomas A. Kämpe, Adam Pawinski, Astrid Dalhaug
Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume
C. Ostheimer, C. Evers, M. Bache, T. Reese, D. Vordermark
Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?
Amedeo A. Azizi, Simon Paur, Alexandra Kaider, Karin Dieckmann, Andreas Peyrl, Monika Chocholous, Thomas Czech, Irene Slavc
Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study
Jaap D. Zindler, Jacqueline Schiffelers, Philippe Lambin, Aswin L. Hoffmann
Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy
Tobias Gauer, Thilo Sothmann, Oliver Blanck, Cordula Petersen, René Werner
Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients
Jan C. Peeken, Josefine Hesse, Bernhard Haller, Kerstin A. Kessel, Fridtjof Nüsslin, Stephanie E. Combs
Effect of continuous positive airway pressure administration during lung stereotactic ablative radiotherapy: a comparative planning study
Dario Di Perri, Andréa Colot, Antoine Delor, Randa Ghoul, Guillaume Janssens, Valérie Lacroix, Pascal Matte, Annie Robert, Kevin Souris, Xavier Geets
Unterschiedliche Letalität nach Operation und stereotaktischer Strahlentherapie beim nicht-kleinzelligen Lungenkarzinom im Frühstadium
Kai J. Borm, Stephanie E. Combs
Fehlender Konsens bei Behandlungskonzepten für makroskopische Rezidive nach radikaler Prostatektomie
Peter Niehoff
Eine engmaschige internetbasierte Patientennachsorge verbessert das Gesamtüberleben von Patienten mit Bronchialkarzinom
Nils Henrik Nicolay